The Latest Breaking News from Clinical Trial

Texas will launch its own clinical trials into ibogaine psychedelic after failing to find a drug company to help

The state’s effort will get a boost from the federal government thanks to a new executive order from President Donald Trump.

The Texas Tribune · Mar 31

‘We have six months to save our daughter’s life before childhood dementia robs her of her future’

Family of two-year-old face the ultimate ‘race against time’ as they fight to access life-saving treatment before it is too late

The Independent UK · Mar 28

From the lab to clinical trials – why a preventative lung cancer vaccine could soon be a reality

It’s the third most common cancer in the UK, causing tens of thousands of deaths annually. But what if the disease, often only diagnosed when it’s too late, could be stopped before it even begins?

The Guardian - UK · Mar 26

New prostate cancer drug showing ‘remarkable’ results during clinical trial

The new drug, known as VIR-5500, uses a so-called cloaking device and only activates when it reaches the tumour

The Independent UK · Feb 28

‘A miracle baby’: Newborn Hugo rewrites medical history after groundbreaking womb transplant

A tiny baby named Hugo has quietly made medical history in the UK. And yet, at its heart, this isn’t really a story about science. It’s about a mother who finally got to hold the child she once believed she would never have. Hugo was born just before Christmas 2025…

Times Life · Feb 27

New oral pill beats previous alternatives and shows 8% weight loss in clinical trials

Eli Lilly’s new oral pill, orforglipron, led to up to 8% weight loss in clinical trials, outperforming existing oral semaglutide alternatives.

Euronews · Feb 27

UK clinical trial into puberty blockers on hold after medicines regulator steps in

Recruitment of children for study delayed after MHRA warns that participants should be no younger than 14

The Guardian - UK · Feb 20

Grail Stock Is Deeply Oversold on Cancer Test Failings. Is There Any Hope Left to Buy the Dip?

Grail stock crashed on Friday after its NHS-Galleri clinical trial failed to meet primary endpoint. Here’s why investors are cautioned against treating GRAL shares as a bargain.

Barchart · Feb 20

Clinical trial into puberty blockers paused after ‘new concerns’ from regulator

It comes after legal action was launched against the Government after campaigners including Harry Potter author JK Rowling expressed their opposition

Evening Standard · Feb 20

Clinical trial into puberty blockers paused after ‘new concerns’ from medicines regulator

The MHRA will now discuss the concerns, related to the wellbeing of children and young people with gender dysphoria, with trial sponsor King’s College London next week

The Independent UK · Feb 20